New Treatises
An error has occurred, which probably means the feed is down. Try again later.
New Answer Books
- The Eleventh Edition has been extensively updated with significant developments across key areas of pharmaceutical regulation, including a new chapter on the FDA’s shift towards greater transparency and its impact on product liability exposure, updated insights on evolving evidence standards for drug approvals, and the latest best practices for navigating FDA inspections and remote regulatory […]
- Q&A guide to the laws governing the pharmaceutical industry. Coverage of FDA regulation and enforcement, regulation of advertising and promotional activity, REMS, product liability, pharmaceutical price reporting, the FDCA, 21st Century Cures Act, and much more.
- The Eleventh Edition has been extensively updated with significant developments across key areas of pharmaceutical regulation, including a new chapter on the FDA’s shift towards greater transparency and its impact on product liability exposure, updated insights on evolving evidence standards for drug approvals, and the latest best practices for navigating FDA inspections and remote regulatory […]
- Covers online privacy policies, the Children’s Online Privacy and Protection Act, mobile device privacy, financial privacy, medical privacy, workplace privacy, online behavioral advertising and tracking, and privacy enforcement and litigation. Includes a chapter on global privacy laws.
- Covers online privacy policies, the Children’s Online Privacy and Protection Act, mobile device privacy, financial privacy, medical privacy, workplace privacy, online behavioral advertising and tracking, and privacy enforcement and litigation. Includes a chapter on global privacy laws.
New Course Handbooks
- The Foreign Corrupt Practices Act (“FCPA”) is at the top of most NY companies’ key risk areas, but the enforcement environment is uncertain given recent federal announcements. Nevertheless, other countries and international organizations continue to ramp up their anti-corruption enforcement, and effective anti-corruption programs continue to be hallmarks of good governance. This program, taught by […]
- The Foreign Corrupt Practices Act (“FCPA”) is at the top of most NY companies’ key risk areas, but the enforcement environment is uncertain given recent federal announcements. Nevertheless, other countries and international organizations continue to ramp up their anti-corruption enforcement, and effective anti-corruption programs continue to be hallmarks of good governance. This program, taught by […]
- PLI’s Annual Elder Law Institute focuses on key issues for attorneys and allied professionals who represent elderly clients or clients with aging parents. This year’s Institute will address the multifaceted practice of elder law, reviewing a range of aspects of aging faced by the elder law practitioner. Experienced practitioners will discuss fundamental and evolving issues such […]
- PLI’s Annual Elder Law Institute focuses on key issues for attorneys and allied professionals who represent elderly clients or clients with aging parents. This year’s Institute will address the multifaceted practice of elder law, reviewing a range of aspects of aging faced by the elder law practitioner. Experienced practitioners will discuss fundamental and evolving issues such […]
- What’s next after a blistering year of M&A activity in 2025? As dealmakers continue to test a more deal-friendly regulatory environment, and with AI investment and rate cuts providing ballast to M&A activity in 2025 (second highest M&A volume year on record!), there are a host of macroeconomic and geopolitical factors – wars, tariffs, interest […]